Update related to the Scheme of Amalgamation of Dhanuka Laboratories Limited ("Amalgamating Company") with Orchid Pharma Limited ("Amalgamated Company/Company") and their respective Shareholders ....
M&A
▲ Positive Development
LOW RISK
📅 Filed on BSE: 10 Jul 2026, 07:33 PM IST · BSE ID: d2c44611-dc53-4ecf-9ab0-8dac7b8ee4c5
View Original BSE Filing (PDF)
💡
In Simple Terms
Orchid Pharma's merger with Dhanuka Laboratories is now officially complete as of July 10, 2026.
🤖 AI Summary
- Orchid Pharma and Dhanuka Laboratories filed the certified NCLT Order with the Registrar of Companies on July 10, 2026.
- The Scheme of Amalgamation became effective on July 10, 2026, following the filing of the NCLT order.
- Dhanuka Laboratories Limited is now amalgamated with Orchid Pharma Limited and dissolved without winding up.
- The Appointed Date for the amalgamation scheme is April 01, 2024, as per the NCLT Order.
🏢 How This Affects the Company
Orchid Pharma Limited now formally incorporates the business operations and assets of Dhanuka Laboratories Limited.
The financial statements of Orchid Pharma Limited will now fully consolidate the financials of Dhanuka Laboratories Limited from the Appointed Date of April 01, 2024.
Orchid Pharma Limited will integrate the operational structures, facilities, and workforce of Dhanuka Laboratories Limited.
The operational and financial risks associated with Dhanuka Laboratories Limited are now directly assumed by Orchid Pharma Limited.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this filing.
👤
Who Is Affected
Shareholders of Orchid Pharma Limited now hold ownership in the combined entity, which includes the assets and liabilities of Dhanuka Laboratories Limited since April 01, 2024.
🔍
Management Signal
The management's action to complete the filing indicates execution of the previously announced strategic amalgamation within the stipulated regulatory framework.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Orchid Pharma's next financial results — assess combined entity performance.
Future disclosures regarding integration progress of Dhanuka Laboratories.
Any further corporate announcements related to the unified business strategy.
LOW RISK
The filing confirms completion of a corporate action, reducing execution uncertainty.
💡 Investor Takeaway
Orchid Pharma Limited has completed the amalgamation with Dhanuka Laboratories Limited, with the scheme becoming effective on July 10, 2026. The NCLT Order has been filed, and the Appointed Date for the merger is April 01, 2024.
⚖️ Strengths & Concerns
✅ Positives
- Completion of amalgamation clarifies the corporate structure, consolidating Dhanuka Laboratories into Orchid Pharma's entity.
- The Appointed Date of April 01, 2024, means the combined entity's financials will reflect the merger's benefits retrospectively.
📅 Company Track Record
Orchid Pharma received the NCLT order for the Dhanuka Laboratories merger on June 12, 2026, with an Appointed Date of April 01, 2024. NCLT had sanctioned the amalgamation on June 05, 2026, following an intimation by Orchid Pharma on March 18, 2026.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
When did Orchid Pharma's amalgamation with Dhanuka Laboratories become effective?
The Scheme of Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited became effective on July 10, 2026.
What was the Appointed Date for the Orchid Pharma-Dhanuka Laboratories merger?
The Appointed Date for the Scheme of Amalgamation between Orchid Pharma Limited and Dhanuka Laboratories Limited is April 01, 2024.
What action was taken by Orchid Pharma on July 10, 2026, regarding the merger?
Orchid Pharma Limited and Dhanuka Laboratories Limited filed the certified copy of the NCLT Order with the Registrar of Companies, Chennai, on July 10, 2026.
Questions based on this BSE filing only. For information purposes.